Evogene Ltd. EVGN
NASDAQ
| 06/30/2026 | 12/31/2025 | 06/30/2025 | 03/31/2025 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -- | -- | 28.26% | 29.16% | 34.62% |
| Total Depreciation and Amortization | -- | -- | -43.70% | -61.39% | 3.97% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -- | -- | -735.21% | -520.15% | -60.28% |
| Change in Net Operating Assets | -- | -- | 57.82% | -24.21% | 64.97% |
| Cash from Operations | -- | -- | 11.04% | -6.85% | 39.30% |
| Capital Expenditure | -- | -- | -24.15% | -6.70% | 27.11% |
| Sale of Property, Plant, and Equipment | -- | -- | -100.00% | -100.00% | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | 235.11% | 240.45% | -120.79% |
| Cash from Investing | -- | -- | 285.15% | 225.38% | -127.97% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | 27.88% | 6.97% | -67.09% |
| Issuance of Common Stock | -- | -- | -32.47% | -31.33% | 56,066.67% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 93.60% | -99.56% | 4.85% |
| Cash from Financing | -- | -- | 28.47% | -72.56% | 86.98% |
| Foreign Exchange rate Adjustments | -- | -- | 61.11% | 70.00% | 89.72% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -- | -- | 89.25% | 60.13% | 21.55% |